NSCs were engineered to release GDNF into degenerated dopaminergic neurons in the SNpc by giving rise to neurons, astrocytes, and oligodendrocytes that expressed stable levels of GDNF for approximately four months and decreased behavioral impairment in PD-affected mice [106]. The gene discussed is GDNF; the disease is Parkinson disease.